Cough syrup issue: Health ministry directs rational use of medication

Union health secretary convened a meeting with states to address drug quality after multiple child deaths linked to contaminated cough syrups like Coldrif, found with DEG/EG. States were directed on rational use, while DGHS advised against prescribing such medicines for children under two, emphasizing careful evaluation for older kids. Probes are underway, and some states have banned the syrups.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fpu3oe4
via IFTTT

Read More

NSE to build Rs 380-crore facility for cancer treatment at Tata Memorial Centre

NSE will build a 380 crore rupee cancer treatment facility at Tata Memorial Hospital. This 11-storey block and bone marrow transplant centre will be in Navi Mumbai. It will serve 1.3 lakh outpatients and conduct over 600 BMTs annually. The facility will have 60 beds. Operations are expected to begin by July 2027.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/E3MQqC6
via IFTTT

Read More

India's TB fight gets a boost: New Made-in-India diagnostic tests cut cost & time

India's ICMR has validated two new indigenous TB diagnostic tools from Huwel Lifesciences. The Quantiplus MTB FAST kit offers cheaper, open-system RT-PCR testing on existing machines, while UniAMP MTB uses non-invasive tongue swabs for patient-friendly diagnosis. These innovations promise faster, more accessible, and affordable TB detection, boosting India's elimination efforts.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HYprjS0
via IFTTT

Read More

Torrent Pharma gets demand notices totalling Rs 6.63 cr from NPPA

Torrent Pharmaceuticals reported receiving demand notices from the NPPA. The notices total over Rs 6.63 crore. They allege overcharging for five drugs between January 2016 and November 2018. The company stated these notices were received on October 3, 2025. Torrent Pharmaceuticals expects no material financial impact from this development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yrTJDqE
via IFTTT

Read More

Health Ministry confirms Diethylene Glycol beyond permissible limits in Coldrif cough syrup amid child deaths in Raj, MP

The Ministry of Health confirmed Coldrif Cough Syrup from Sresan Pharma's Kanchipuram unit contained diethylene glycol (DEG) above permissible limits, following investigations into child deaths in Madhya Pradesh and Rajasthan. Tamil Nadu banned its sale, halting production. Authorities initiated risk-based inspections and advised against prescribing cough syrup to children under two.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Q1aO7u2
via IFTTT

Read More

Tamil Nadu bans ''Coldrif'' cough syrup after child deaths in MP, Rajasthan

Tamil Nadu has banned the sale of 'Coldrif' cough syrup, manufactured by a city-based firm, following suspicions linking it to 11 child deaths in Madhya Pradesh and Rajasthan. Inspections were conducted, and samples are being tested for Diethylene Glycol. The Union Health Ministry also advised against prescribing cough and cold medications for children under two years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/y2LmXx6
via IFTTT

Read More

Isabgol processors threaten to halt purchases from October 6 over GST

Isabgol processors threaten to halt purchases from farmers due to GST ambiguities, locking up capital for over a year. The industry, exporting ₹3,500 crore annually, faces financial stress and slowed exports as unclear classifications force them to pay GST on seeds, despite refunds. They demand government clarification.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/szVjFdB
via IFTTT

Read More

Indian Pharmaceutical Alliance appoints Zydus Lifesciences MD Sharvil Patel as new president

The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel of Zydus Lifesciences as its new President, with Glenn Saldanha of Glenmark as Vice President. This leadership transition occurs as the industry navigates GST reforms and strengthens its global position in specialty medicines. The new team aims to drive innovation, patient access, and quality healthcare solutions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/h4iGfDN
via IFTTT

Read More

IPA names Zydus Lifesciences MD Sharvil Patel as President

Sharvil Patel is the new president of the Indian Pharmaceutical Alliance. He takes over from Samir Mehta. Glenn Saldanha becomes the vice president. The IPA represents 23 national pharmaceutical companies. The new team will build on reforms and breakthroughs. They will focus on innovation, patient access, and quality in healthcare.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GYj4I3U
via IFTTT

Read More

Panacea Biotec gets supply order from UNICEF for oral polio vaccines worth Rs 315 cr

Panacea Biotec has received a long-term supply order from UNICEF. The order is for bivalent oral polio vaccines. It is valued at USD 35.65 million. Supplies will commence from April 2026 and continue until March 2030. This agreement covers vaccine requirements for UNICEF. The company will provide vaccines in 10 and 20 vial presentations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ra1qZi5
via IFTTT

Read More

Government invites proposals under PRIP scheme for industry, startup projects

The government has invited applications for its Rs 5,000 crore Pharma-MedTech innovation scheme, aiming to support around 300 projects in new medicines, biosimilars, and medical devices. Revised guidelines offer enhanced financial assistance for MSMEs and startups, including higher support for strategic priority areas. Applications opened on October 1 via a digital portal.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zx32rmn
via IFTTT

Read More

Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say

Semaglutide, the active ingredient in Novo's Wegovy and Ozempic, and tirzepatide, sold as Zepbound and Mounjaro by Lilly, are so effective that they should be the first choice in almost all cases when substantial weight loss is necessary, according to a new guideline from the European Association for the Study of Obesity published in Nature Medicine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MtGbVzl
via IFTTT

Read More

Pricing depends on the country, Bayer looks at affordability: Executive

India has evolved significantly in the clinical trial setting...we have a significant number of patients and trials running in IndiaAshraf Al-Ouf Head, Pharmaceutical Commercial Ops, APAC, Bayer

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HNKCDW5
via IFTTT

Read More

'Contaminated' cough syrup linked deaths: NCDS collects water, entomological drug samples

NCDC collected water and entomological drug samples from Madhya Pradesh and Rajasthan after multiple children died of kidney failure, allegedly linked to contaminated cough syrup. These samples will be tested for infectious diseases, while state drug authorities await results from drug sample tests. Six children died in MP and one in Rajasthan, prompting a ban on 19 syrup batches.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Pf9E8HG
via IFTTT

Read More

Indian pharma Wockhardt seeks US approval for new drug to treat UTIs

Wockhardt has submitted a New Drug Application to the USFDA for its novel antibacterial agent, Zidebactam-Cefepime injection. This drug targets complicated urinary tract infections, including those caused by multidrug-resistant Gram-negative bacteria. This marks a significant milestone as the first USFDA NDA for a drug fully discovered and developed by an Indian pharmaceutical company, following successful global Phase III trials.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RVx0eK2
via IFTTT

Read More